OTI Lumionics Raises $55 Million in Series B Funding and Completes Customer Mass Production Qualification of its Display Materials

The company’s technology enables the front facing camera and other sensors to be integrated under the display, eliminating notches and cut-outs in mobile devices screens

Erwin Estigarribia is Appointed President and Chief Operating Officer of InterVenn Biosciences

InterVenn is focusing on the development and commercialization of its Advanced Adenoma and Colorectal Cancer screening platform to change the paradigm for the detection of early-stage disease

AM Batteries (AMB) Secures $25M Series A Financing to Scale Manufacturing of Novel Lithium-Ion Dry-Electrode Technology

AM Batteries (AMB) is a Boston-based innovative manufacturing company developing a next-generation, lower-carbon footprint and lower cost dry-electrode manufacturing technology for lithium-ion batteries

Xendee Microgrid Design Platform Adds New Feature to Help Engineers Take Advantage of Inflation Reduction Act Incentives

Xendee platform now offers tools to apply these incentives directly to the technologies during the modeling process.

Excision BioTherapeutics to Host Key Opinion Leader Webinar on HIV and the Ongoing Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure

Webinar will focus on the unmet medical need in HIV, therapeutic applications of gene delivery and editing for treatment of viral disease, and the Company’s ongoing Phase 1/2 trial evaluating the CRISPR-based therapy, EBT-101, as a treatment for HIV

6K Awarded Prestigious Department of Energy Grant to Fund $107M UniMelt Plasma Processing Plant for Domestic Battery Material Production

The new plant will demonstrate the ability to domestically produce multiple battery chemistries in the same
factory with the capacity of 3,000 tons per annum (tpa) in 2025 scaling to 10,000 tpa in 2026

BioSkryb Genomics and Cooper Surgical Ink Multi-Year Deal to Accelerate Clinical Discovery and Diagnostics in Women’s Reproductive Health

New partnership brings transformative, high-resolution single-cell genomic technology to the field of preimplantation genetic testing in the pursuit of improved discovery and clinical outcomes.

e-Zinc Works with Silicon Valley Bank and Secures USD $7 Million Venture Debt Facility

The funding will be used to expand production at e-Zinc’s new Mississauga, ON facility and accelerate commercialization efforts

e-Zinc CEO James Larsen Named to Canada’s 2023 Clean50

e-Zinc announced that its CEO James Larsen was named one of Canada’s 2023 Clean50 in the research and development category.

InterVenn Biosciences Co-Founder Carolyn Bertozzi Awarded Nobel Prize in Chemistry

InterVenn Biosciences announced that its co-founder Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in chemistry.